THE FOLLOW UP
STATEMENT

TrumpRx.gov launch includes drugs from five manufacturers with MFN pricing deals

True

Evidence from credible sources supports the statement as accurate. Learn more in Methodology.

Interesting: 0/0 • Support: 0/0Log in to vote
other

Drugs from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer are listed on TrumpRx.gov under MFN pricing deals.

Source summary
The White House announced the launch of TrumpRx.gov, a website that offers patients discounted prices on branded medicines by matching the lowest prices paid by other developed countries (most‑favored‑nation or MFN pricing). The launch includes deals from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer and lists price reductions for 40 costly drugs, including steep cuts for Ozempic, Wegovy, fertility medicines, and insulin. The fact sheet notes prior executive actions and deals announced since 2025, and a separate U.S. agreement with the U.K. intended to raise net U.K. drug prices by 25%.
View original article →
Latest fact check

The White House fact sheet for Feb. 5, 2026, explicitly states the TrumpRx launch “features drugs made by the first five manufacturers to reach MFN pricing deals with the Trump Administration: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer.” Independent reporting from NPR, CNBC and Reuters corroborates that the site debuted with discounted medicines from those five companies (NPR reported 43 drugs at launch). Verdict: True — contemporaneous White House documentation and multiple independent news outlets confirm the administration’s claim that the launch included drugs from those five manufacturers that had reached most-favored-nation (MFN) pricing deals.

Sources

Timeline

  1. Update · Feb 06, 2026, 10:06 AMTrue
    The White House fact sheet for Feb. 5, 2026, explicitly states the TrumpRx launch “features drugs made by the first five manufacturers to reach MFN pricing deals with the Trump Administration: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer.” Independent reporting from NPR, CNBC and Reuters corroborates that the site debuted with discounted medicines from those five companies (NPR reported 43 drugs at launch). Verdict: True — contemporaneous White House documentation and multiple independent news outlets confirm the administration’s claim that the launch included drugs from those five manufacturers that had reached most-favored-nation (MFN) pricing deals.
  2. Original article · Feb 05, 2026
    View article
Back to Countdowns

Comments

Only logged-in users can comment.
Loading…